Investing.com - Ionis Pharma (NASDAQ: IONS) reported third quarter EPS of $-1.03, in line with the analyst estimate of $-1.03. Revenue for the quarter came in at $144M versus the consensus estimate of $132.91M.
Ionis Pharma's stock price closed at $45.26. It is up 13.89% in the last 3 months and up 1.73% in the last 12 months.
Ionis Pharma saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Ionis Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Ionis Pharma's Financial Health score is "fair performance".
Check out Ionis Pharma's recent earnings performance, and Ionis Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar